Oruka Therapeutics, Inc. ORKA Investment Income Interest
Investment Income Interest at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s investment income interest.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s investment income interest?
- Oruka Therapeutics, Inc. (ORKA) reported investment income interest of $4.61M in Q1 2026.
- How has Oruka Therapeutics, Inc.'s investment income interest changed year-over-year?
- Oruka Therapeutics, Inc.'s investment income interest increased by 12.6% year-over-year, from $4.09M to $4.61M.
- What does investment income interest mean?
- Reflects the interest income earned on cash balances, marketable securities, and other short-term financial investments. This metric highlights the company's ability to generate returns on its idle capital reserves.